Senegal launches new phase of hepatitis B project to improve patient care
Summary and headline written by AI from the source article. How we work
The SEN-B project launched a new phase of activities in Senegal to improve the monitoring and treatment of hepatitis B patients.
This initiative began in 2019 and aims to enhance medical research, train young researchers, and provide better healthcare access for those living with the disease. Professor Bamba Kane, who coordinates the national program to fight hepatitis in Senegal, says the project has already provided free medical care to more than 1,000 patients.
These services include medical consultations, ultrasounds, laboratory tests, and treatments. The cost of care for a single patient can reach 300,000 FCFA and may include certain surgical procedures. During the 2026 to 2030 phase, researchers will focus on evaluating treatments like tenofovir and studying the social and economic obstacles that prevent patients from completing long-term medical plans.
Professor Gilles Vandler from the University of Berne, a specialist in infectious diseases, says the data collected over the last eight to nine years will help officials anticipate how hepatitis B will evolve in Senegal. The project currently operates on an announced budget of approximately 200,000 euros per year for the four years of planned monitoring. However, Vandler says these resources are limited compared to the medical and scientific needs of the 1,000 person cohort.
Project leaders are seeking stronger partnerships with Senegalese authorities to secure more funding, ensure the continuity of care, and improve access to tenofovir.
